Regulatory role of CD40 in obesity-induced insulin resistance

Adipocyte

Volumn 4, Issue 1, 2015, Pages 65-69

  Yi, Zuoan ^a   Bishop, Gail A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CD40; Gut microbiota; Insulin resistance; Mucosal immunity; Obesity; T cell

Indexed keywords

CD40 LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; DIET INDUCED OBESITY; ENDOPLASMIC RETICULUM STRESS; HUMAN; HYPER IGM SYNDROME; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; MICROENVIRONMENT; MUCOSAL IMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 85050577619     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.4161/adip.32214     Document Type: Article

References (50)

1. Johnson AM1, Olefsky JM. The origins and drivers of insulin resistance. Cell 2013; 152: 673-84; PMID: 23415219; http: //dx. doi. org/10. 1016/j. cell. 2013. 01. 041
2. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013; 17: 851-9; PMID: 23747244; http: //dx. doi. org/10. 1016/j. cmet. 2013. 05. 008
3. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97; PMID: 21252989; http: //dx. doi. org/ 10. 1038/nri2921
4. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808; PMID: 14679176; http: // dx. doi. org/10. 1172/JCI200319246
5. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30; PMID: 14679177; http: //dx. doi. org/10. 1172/JCI200319451
6. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, et al. CD8C effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-20; PMID: 19633658; http: // dx. doi. org/10. 1038/nm. 1964
7. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-9; PMID: 19633657; http: //dx. doi. org/ 10. 1038/nm. 2001
8. Hotamisligil GS1, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91; PMID: 7678183; http: //dx. doi. org/ 10. 1126/science. 7678183
9. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505; PMID: 16691291; http: //dx. doi. org/10. 1172/JCI26498
10. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011; 12: 408-15; PMID: 21478880; http: //dx. doi. org/10. 1038/ni. 2022
11. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-34; PMID: 11466099; http: //dx. doi. org/10. 1001/ jama. 286. 3. 327
12. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-45; PMID: 21219177; http: //dx. doi. org/10. 1146/ annurev-immunol-031210-101322
13. Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR-g is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012; 486: 549-53; PMID: 22722857
14. Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, Stephens JM, Mynatt RL, Dixit VD. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010; 185: 1836-45; PMID: 20581149; http: //dx. doi. org/10. 4049/jimmunol. 1000021
15. Wagner DH Jr, Vaitaitis G, Sanderson R, Poulin M, Dobbs C, Haskins K. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci U S A 2002; 99: 3782-7; PMID: 11891296; http: //dx. doi. org/10. 1073/pnas. 052247099
16. Munroe ME, Bishop GA. A costimulatory function for T cell CD40. J Immunol 2007; 178: 671-82; PMID: 17202327; http: //dx. doi. org/10. 4049/jimmunol. 178. 2. 671
17. Graham JP, Arcipowski KM, Bishop GA. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol Rev 2010; 237: 226-48; PMID: 20727039; http: //dx. doi. org/ 10. 1111/j. 1600-065X. 2010. 00932. x
18. Callard E, Armitage RJ, Fanslow WC, Spriggs MK. CD40L and its role in X-linked hyper-IgM syndrome. Immunol Today 1993; 14: 559-64; PMID: 7506037; http: //dx. doi. org/10. 1016/0167-5699(93)90188-Q
19. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40L mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541-3; PMID: 8094231; http: //dx. doi. org/10. 1038/361541a0
20. Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste CS. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 2006; 116: 2366-77; PMID: 16955139; http: //dx. doi. org/10. 1172/JCI28796
21. Renshaw BR, Fanslow WC 3rd, Armitage RJ, Campbell KA, Liggitt D, Wright B, Davison BL, Maliszewski CR. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994; 180: 1889-900; PMID: 7964465; http: //dx. doi. org/10. 1084/jem. 180. 5. 1889
22. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167-78; PMID: 7534202; http: //dx. doi. org/10. 1016/1074-7613 (94)90095-7
23. Khong A, Nelson DJ, Nowak AK, Lake RA, Robinson BW. The use of agonistic anti-CD40 therapy in treatments for cancer. Int Rev Immunol 2012; 31: 246-66; PMID: 22804570; http: //dx. doi. org/10. 3109/ 08830185. 2012. 698338
24. Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Sisman AR, Yuksel F, Yesil S. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res 2010; 8: 89-95; PMID: 20660932; http: //dx. doi. org/10. 3121/cmr. 2010. 889
25. Poggi M, Engel D, Christ A, Beckers L, Wijnands E, Boon L, Driessen A, Cleutjens J, Weber C, Gerdes N, et al. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscler Thromb Vasc Biol 2011; 31: 2251-60; PMID: 21817098; http: //dx. doi. org/10. 1161/ ATVBAHA. 111. 231357
26. Wolf D, Jehle F, Ortiz Rodriguez A, Dufner B, Hoppe N, Colberg C, Lozhkin A, Bassler N, Rupprecht B, Wiedemann A, et al. CD40L deficiency attenuates dietinduced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies. PLoS One 2012; 7: e33026; PMID: 22412980; http: //dx. doi. org/10. 1371/journal. pone. 0033026
27. Villeneuve J, Lepreux S, Mulot A, Bérard AM, Higa-Nishiyama A, Costet P, De Ledinghen V, Bioulac-Sage P, Balabaud C, Nurden AT, et al. A protective role for CD154 in hepatic steatosis in mice. Hepatology 2010; 52: 1968-79; PMID: 21064031; http: //dx. doi. org/ 10. 1002/hep. 23935
28. Guo CA, Kogan S, Amano SU, Wang M, Dagdeviren S, Friedline RH, Aouadi M, Kim JK, Czech MP. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis and insulin resistance. Am J Physiol Endocrinol Metab 2013; 304: E951-63; PMID: 23482447; http: //dx. doi. org/ 10. 1152/ajpendo. 00514. 2012
29. Yi Z, Stunz LL, Bishop GA. CD40-mediated maintenance of immune homeostasis in the adipose tissue microenvironment. Diabetes 2014; 63: 2751-60; PMID: 24647739; http: //dx. doi. org/10. 2337/db13-1657
30. Wolf D, Jehle F, AntoMichel N, Bukosza EN, Rivera J, Chen YC, Hoppe N, Dufner B, Ortiz Rodriguez A, Colberg C, et al. Co-Inhibitory Suppression of T Cell Activation by CD40 Protects from Obesity and Adipose Tissue Inflammation in Mice. Circulation 2014; 129: 2414-25; PMID: 24664276; http: //dx. doi. org/ 10. 1161/CIRCULATIONAHA. 113. 008055
31. Law CL, Grewal IS. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv Exp Med Biol 2009; 647: 8-36; PMID: 19760064; http: //dx. doi. org/10. 1007/978-0-387-89520-8_2
32. Bishop GA. The many faces of CD40: multiple roles in normal immunity and disease. Semin Immunol 2009; 21: 255-6; PMID: 19713124; http: //dx. doi. org/ 10. 1016/j. smim. 2009. 08. 002
33. Bishop GA, Moore CR, Xie P, Stunz LL, Kraus ZJ. TRAF proteins in CD40 signaling. Adv Exp Med Biol 2007; 597: 131-51; PMID: 17633023; http: //dx. doi. org/10. 1007/978-0-387-70630-6_11
34. Baccam M, Bishop GA. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaBindependent IL-6 production in B cells. Eur J Immunol. 1999; 29: 3855-66; PMID: 10601993; http: //dx. doi. org/10. 1002/(SICI)1521-4141(199912) 29: 12%3c3855:: AID-IMMU3855%3e3. 0. CO; 2-S
35. Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, van den Berg S, van den Berg S, Soehnlein O, Winkels H, Beckers L, et al. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc Natl Acad Sci U S A 2014; 111: 2686-91; PMID: 24492375; http: //dx. doi. org/ 10. 1073/pnas. 1400419111
36. El Fakhry Y, Alturaihi H, Diallo D, Merhi Y, Mourad W. Critical role of lipid rafts in CD154-mediated T cell signaling. Eur J Immunol 2010; 40: 770-9; PMID: 20039299; http: //dx. doi. org/10. 1002/eji. 200939646
37. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, et al. CD40L mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007; 115: 1571-80; PMID: 17372166; http: //dx. doi. org/10. 1161/CIRCULATIONAHA. 106. 683201
38. Bourgeois C, Rocha B, Tanchot C. A role for CD40 expression on CD8C T cells in the generation of CD8C T cell memory. Science 2002; 297: 2060-3; PMID: 12242444; http: //dx. doi. org/10. 1126/science. 1072615
39. Johnson S, Zhan Y, Sutherland RM, Mount AM, Bedoui S, Brady JL, Carrington EM, Brown LE, Belz GT, Heath WR, et al. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity 2009; 30: 218-27; PMID: 19200758; http: // dx. doi. org/10. 1016/j. immuni. 2008. 11. 015
40. Seah SG, Brady JL, Carrington EM, Ng WC, Sutherland RM, Hancock MS, La Gruta NL, Brown LE, Turner SJ, Lew AM, et al. Influenza-induced, helperindependent CD8C T cell responses use CD40 costimulation at the late phase of the primary response. J Leukoc Biol 2013; 93: 145-54; PMID: 23108101; http: //dx. doi. org/10. 1189/jlb. 0612266
41. Bhadra R, Gigley JP, Khan IA. Cutting edge: CD40-CD40L pathway plays a critical CD8-intrinsic and-extrinsic role during rescue of exhausted CD8 T cells. J. Immunol 2011; 187: 4421-5; PMID: 21949017; http: //dx. doi. org/10. 4049/jimmunol. 1102319
42. Martin S, Pahari S, Sudan R, Saha B. CD40 signaling in CD8CCD40C T cells turns on contra-T regulatory cell functions. J. Immunol 2010; 184: 5510-8; PMID: 20400702; http: //dx. doi. org/10. 4049/ jimmunol. 0902762
43. Sun JC, Bevan MJ. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol 2004; 172: 3385-9; PMID: 15004136; http: //dx. doi. org/ 10. 4049/jimmunol. 172. 6. 3385
44. Lee BO, Hartson L, Randall TD. CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J Exp Med 2003; 198: 1759-64; PMID: 14657225; http: //dx. doi. org/10. 1084/jem. 20031440
45. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-81; PMID: 18305141; http: //dx. doi. org/10. 2337/db07-1403
46. Cerf-Bensussan N1, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10: 735-44; PMID: 20865020; http: //dx. doi. org/10. 1038/nri2850
47. Perona-Wright G, Jenkins SJ, O'Connor RA, Zienkiewicz D, McSorley HJ, Maizels RM, Anderton SM, MacDonald AS. A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo. J Immunol 2009; 182: 2808-15; PMID: 19234175; http: //dx. doi. org/ 10. 4049/jimmunol. 0803553
48. Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ, Kopf M. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4C T cells. Proc Natl Acad Sci U S A 2009; 106: 876-81; PMID: 19136631; http: //dx. doi. org/10. 1073/pnas. 0810769106
49. Bergqvist P, Stensson A, Lycke NY, Bemark M. T cellindependent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation. J Immunol 2010; 184: 3545-53; PMID: 20207993; http: //dx. doi. org/ 10. 4049/jimmunol. 0901895
50. Chatzigeorgiou A, Phieler J, Gebler J, Bornstein SR, Chavakis T. CD40L stimulates the crosstalk between adipocytes and inflammatory cells. Horm Metab Res 2013; 45: 741-7; PMID: 23918687; http: //dx. doi. org/ 10. 1055/s-0033-1348221